A double-blind, randomized, placebo-controlled, cross-over, allergen challenge study to evaluate taste and local tolerance of NLA nasal spray in patients with allergic rhinitis

Trial Profile

A double-blind, randomized, placebo-controlled, cross-over, allergen challenge study to evaluate taste and local tolerance of NLA nasal spray in patients with allergic rhinitis

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Mar 2008

At a glance

  • Drugs Cetirizine (Primary)
  • Indications Allergic rhinitis
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Mar 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 06 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top